SAVA
NASDAQ
$2.38
Cassava Sciences Inc. (SAVA)
Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Target: $8 (+236.13%)
Market Cap
$115M
P/B Ratio
0.92
EPS 5Y CAGR
+43.62%
FCF 5Y CAGR
+36.14%
Price Chart
Valuation
Market Cap$115M
Forward P/E151.52
P/S2.54
P/B0.92
Profitability
Gross Profit (TTM)-$43M
EBITDA-$81M
Profit Margin93.7%
Operating Margin93.4%
EPS-$1.61
Financial Health
Free Cash Flow Yield-26.42%
Growth & Risk
EPS 5Y CAGR+43.62%
FCF 5Y CAGR+36.14%